Arbutus Biopharma Corp (ABUS)

Net Income Growth

-303.84%

Quarterly · Period ending:

ABUS logo

ABUS Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-303.84%
ABUS Quarterly Net Income YoY % (1.39% → -303.84%)
High-resolution chart · PNG

ABUS net income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Net Income Growth — Quarterly
Period endingNet Income Growth
-303.8446%
791.8984%
70.0287%
60.7344%
112.745%
-37.2084%
35.1077%
1.925%
-15.8067%
-9.4008%
11.946%
-14.4419%
-20.4481%
-3.641%
-2.8657%
8.3046%
26.7963%
3.7605%
-25.1086%
-2.1488%
-37.6233%
-18.1805%
30.8753%
77.2675%
39.5797%
40.3854%
-35.0978%
-237.1185%
-854.2866%
-33.4041%
49.211%
-110.9741%
116.9323%
6.4315%
83.5703%
40.8012%
85.9577%
-17.3428%
-4,054.5403%
32.3891%
-772.4832%
-32.4047%
14.6563%
-236.8433%
-145.0255%
33.3352%
-135.8122%
-45.9198%
-106.0528%
-597.747%
-106.7758%
-68.9309%
-56.0633%
18.6191%
2,102.5219%
-146.513%
48.1468%
0.6309%
-32.9431%
45.5532%
8.7206%
26.4488%
44.8636%
1.799%
-106.067%
-163.6245%
-151.5324%
53.4481%
59.2456%
-289.9343%
-392.1728%
-475.3642%
1.3867%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.